share_log

和铂医药-B(02142.HK)将于3月28日举行董事会会议以审批全年业绩

Hebo Pharmaceutical-B (02142.HK) will hold a board meeting on March 28 to approve the annual results

Gelonghui Finance ·  Mar 13 05:57

On March 13, Gelonghui Pharmaceutical-B (02142.HK) announced that the company will hold a board meeting on March 28, 2024 to consider and approve the Group's annual results for the year ended December 31, 2023, and deal with other matters.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment